Mast cell activation syndrome (MCAS) affects more than 15% of the U.S. population but evades most practitioners’ radar. Just five years ago, it wasn’t even on my radar, despite already having 20 years of experience as a clinician at that time. The more I dug (similar to leaky gut and post-COVID syndrome), the more I found my patients were suffering from this disorder.
Thomas Hodge, DOM
Dr. Thomas Hodge is an associate clinician working alongside Dr. Jason Hao in their Santa Fe clinic where they specialize in the treatment of neuroinflammatory and neurodegenerative diseases such as multiple sclerosis and Parkinson's disease and the sequela of stroke. In addition to his work with Dr. Hao, Dr. Hodge's clinical experiences include Christus St. Vincent's Cancer Center and Rehabilitation Center, and Santa Fe Indian Hospital. He is an executive board member of Neuro-acupuncture Institute 501(c)3 and a member of the World Federation of Chinese Medicine Societies' subcommittee for brain research.